Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EFCAB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NEBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIRC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFPI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR60 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NADK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL22A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCN7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF641 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAGE12D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR10A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on